Protea Biosciences Group (OTCQB:PRGB) announced it is teaming up with software provider Protein Metrics to advance the development of protein biotherapeutics.
Greg Kilby, Protea’s vice president and chief operating officer, said: “We are positioning Protea to be a leader in the next generation of bioanalytics, focused on the needs of the biotherapeutics industry.”
The collaboration will provide Protea access to advanced analytics software, allowing the two to combine technologies.
“Biopharma is in need of these new bioanalytical capabilities,” Protea’s Kilby said.
Chris Becker, chief executive of Protein Metrics, said: “We are delighted to partner with Protea Biosciences and are looking forward to seeing our software advance the results they provide their clients.”